{
    "nctId": "NCT04784182",
    "briefTitle": "Anti-anxiety Biotics for Breast Cancer Survivors",
    "officialTitle": "Synbiotic Supplementation to Reduce Anxiety Symptoms in Female Breast Cancer Survivors and/or Their Female Relatives",
    "overallStatus": "TERMINATED",
    "conditions": "Anxiety Generalized, Breast Cancer Female",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 3,
    "primaryOutcomeMeasure": "Feasibility - Accrual",
    "eligibilityCriteria": "Inclusion Criteria:\n\nFemale breast cancer survivors or female relatives of a breast cancer survivor who:\n\n1. are 50 years of age or older\n2. have completed primary treatment\n3. currently experience clinical anxiety symptoms determined by the 7 item Generalized Anxiety Disorder screener (GAD-7; eligibility requires a total score of 5 or higher on the 21 point scale)\n4. agree not to change dietary supplements throughout the course of the study\n5. are willing to comply with daily supplement regimen\n6. are able to speak and read English.\n\nExclusion Criteria:\n\n1. use of any of the following drugs within the last 4 weeks (unless indefinitely prescribed): systemic antibiotics, corticosteroids, immunosuppressive agents, or commercial probiotics\n2. changes in treatment for anxiety symptoms (i.e. initiation of Cognitive Behavior Therapy (CBT) within the last four weeks\n3. current use (within 12 weeks) of anxiolytic medications.",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}